Abstract
Loss of Hormone Receptors (HR) at metastatic (met) relapse has been widely described in breast cancer (BC). Higher TILs have been associated with better prognosis in patients (pts) with early triple-negative (TN) BC, but to worse outcome in HR-positive (HR+)/HER2- BC. TILs significance in pts with HR-loss has never been investigated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
